Topic
Asian access
Page 6 of 15 — Japanese approval and clinic pricing, Korean clinic culture, Singapore, Hong Kong, and the Indian generics landscape.
Messages — page 6 of 15
vat_on_importhow careful should i be about the claims on an indian generic#asia · 2025-11-16sgp_subqis japan expensive because of the approval or in spite of it#asia · 2025-11-16vat_on_importjapan approved it#asia · 2025-11-16quiet_head_qihong kong members reported both clinic and pharmacy routes and a wide price range between the two#asia · 2025-11-17quiet_head_qisingapore customs, is a personal quantity fine#asia · 2025-11-17identity_shifti was wrong about japanese pricing by a factor of two when i quoted it in here, because i was quoting a clinic and somebody…#asia · 2025-11-17identity_shiftjapanese insurance covered the diabetes indication and not the weight one as far as anyone here could establish a year ago#asia · 2025-11-17secretagogue_syjapan approved it for both indications a while ago as i understood it, and the approval did not make it cheap#asia · 2025-11-17secretagogue_sythe honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way#asia · 2025-11-20underfill_umakorea is fast#asia · 2025-11-20seoul_swirlsingapore was reported in here at around 400 to 600 singapore dollars a month a year or so ago, prescription only#asia · 2025-11-20factory_direct_fias of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described#asia · 2025-11-20hair_month_foursingapore handles personal quantities of prescription medicine under its own rules and i would not try to summarise them from…#asia · 2025-11-20tokyo_taperjapan approved it#asia · 2025-11-23tokyo_tapera member in hong kong and a member in singapore compared the same dose and came out about forty percent apart, still working…#asia · 2025-11-23factory_direct_fihong kong, is it pharmacy or clinic in practice#asia · 2025-11-23seoul_swirlas of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described#asia · 2025-11-23factory_direct_fijapan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price#asia · 2025-11-23patent_2026quick one japanese insurance covered the diabetes indication and not the weight one as far as anyone here could establish a…#asia · 2025-11-23sgp_subqkorea is fast#asia · 2025-11-23sgp_subqok so i treat a claim about an indian generic the way i treat any claim about any product. get a lot number and get it tested#asia · 2025-11-23c18_columnkorea has a clinic culture where this is straightforward to obtain, and members reported that as both a convenience and a…#asia · 2025-11-23c18_columnsorry to jump in singapore was reported in here at around 400 to 600 singapore dollars a month a year or so ago, prescription…#asia · 2025-11-23thank_you_year_ongetting seen in korea was faster than any route a uk member described at the time we were both describing it#asia · 2025-11-23thank_you_year_onthe honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way#asia · 2025-11-23thank_you_year_onright so is japan expensive because of the approval or in spite of it singapore handles personal quantities of prescription…#asia · 2025-11-23mira_pinssorry to jump in is it easier to get seen about this in korea than in europe#asia · 2025-12-06sgp_subqhong kong members reported both clinic and pharmacy routes and a wide price range between the two#asia · 2025-12-06sgp_subqhong kong, is it pharmacy or clinic in practice#asia · 2025-12-06cold_chain_cmdrunrelated but korea and the clinic culture, is it as easy to get as people say#asia · 2025-12-06cold_chain_cmdri was wrong about japanese pricing by a factor of two when i quoted it in here, because i was quoting a clinic and somebody…#asia · 2025-12-06lisbon_lotunrelated but the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry,…#asia · 2025-12-06lisbon_lotsingapore was reported in here at around 400 to 600 singapore dollars a month a year or so ago, prescription only#asia · 2025-12-06manila_meniscusjapan approved it for both indications a while ago as i understood it, and the approval did not make it cheap#asia · 2025-12-06manila_meniscusjapan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price#asia · 2025-12-06factory_direct_fidoes anyone in hong kong want to compare prices#asia · 2025-12-06factory_direct_fias of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described, anyway#asia · 2025-12-06two_three_liftsjapanese insurance covered the diabetes indication and not the weight one as far as anyone here could establish a year ago#asia · 2025-12-06two_three_liftsa korean member said their clinic visit took under an hour end to end, which is not a claim about the quality of the assessment#asia · 2025-12-06two_three_liftskorea is fast#asia · 2025-12-06manila_meniscussingapore handles personal quantities of prescription medicine under its own rules and i would not try to summarise them from…#asia · 2025-12-06manila_meniscuswhat does a month come to in singapore dollars#asia · 2025-12-06sgp_subqsingapore customs, is a personal quantity fine#asia · 2025-12-06quiet_head_qikorea and the clinic culture, is it as easy to get as people say japan being expensive despite the approval is the pattern.…#asia · 2025-12-13sgp_subqfor the archive the honest position on india is that i have seen good material and bad material and the paperwork told me…#asia · 2025-12-13sgp_subqi treat a claim about an indian generic the way i treat any claim about any product. get a lot number and get it tested#asia · 2025-12-13seoul_swirlanyone compared a japanese pharmacy price against a private clinic in the region#asia · 2025-12-13hydrate_hanai treat a claim about an indian generic the way i treat any claim about any product. get a lot number and get it tested#asia · 2026-01-03hydrate_hanaare the indian products the same compounds or something else entirely#asia · 2026-01-03hydrate_hanasorry to jump in japan approved it for both indications a while ago as i understood it, and the approval did not make it cheap#asia · 2026-01-03secretagogue_sythe indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is…#asia · 2026-01-03secretagogue_syjapan approved it#asia · 2026-01-03sgp_subqkorea is fast#asia · 2026-01-06sgp_subqcoming back to this japan being expensive despite the approval is the pattern. approval sets the licence and the pricing…#asia · 2026-01-06underfill_umaa korean member said their clinic visit took under an hour end to end, which is not a claim about the quality of the…#asia · 2026-01-06quiet_head_qiwhat does a month come to in singapore dollars#asia · 2026-01-06manila_meniscussorry to jump in are the indian products the same compounds or something else entirely#asia · 2026-01-09secretagogue_syjapan approved it#asia · 2026-01-09quiet_head_qisingapore pricing, anyone able to put a number on it#asia · 2026-01-09hydrate_hanakorea is fast#asia · 2026-01-09